Le Lézard
Classified in: Health
Subject: FEA

PolyNovo's NovoSorb® BTM technology featured in a new digital film series presented by the ICBA and produced by BBC StoryWorks Commercial Productions


MELBOURNE, Australia, July 29, 2021 /PRNewswire/ -- A new digital film series presented by the ICBA and produced by BBC StoryWorks Commercial Productions, uncovers the stories of innovation using nature's building blocks to change the world every day through biotechnology. This exploratory online video series uncovers the powerful stories of innovation in biotechnology and includes a film on PolyNovo's NovoSorb® BTM technology.

Biotechnology promises to revolutionise people's everyday lives, from what they eat, to the fuel they use and the medical treatments they receive. Attention on the biotech industry has never been higher, as pressure is building to respond to pressing environmental and health challenges, and to meet the evolving needs of a growing population.

A new series called Nature's Building Blocks has been produced by BBC StoryWorks the commercial content division of BBC Global News and presented by ICBA. This exciting new film series uncovers the stories of innovation changing the world every day by harnessing the power of nature, and highlights some of the most pioneering and innovative organisations in this sector. Nature's Building Blocks explores the partnerships being formed across the world to improve the lives of people across the globe and the stories behind the science.

PolyNovo's film tells the story of John Weeks who suffered burns to 75% of his body from an explosion in his car. As the first burns patient to be treated with NovoSorb® BTM, the film follows his story and gains an insight into how burn injuries have a profound impact on the lives of survivors and their families. BTM is a versatile reconstructive option for managing burns and aids in facilitating wound closure by providing a vascularised layer to enable secondary skin grafting. This enabled John to not only survive his injuries, but to go on and lead a fulfilling life.

The film features Professor John Greenwood who was the driving force behind the development of BTM. He understood the clinical need for a synthetic skin replacement solution and was driven to find a solution after treating many patients repatriated to Australia after the Bali bombing. Together with Tim Moore, the chief scientist at PolyNovo, they developed NovoSorb BTM and pioneered this paradigm shift in the management of burns.

Simon Shelley, vice president of BBC Programme Partnerships ? part of BBC StoryWorks, said: "We set out to explore the innovations and partnerships that are driving forward biotechnology industries, through the personal stories of the people behind the science ? and those whose lives and livelihoods depend on it."

Nature's Building Blocks is available to explore here ? www.naturesbuildingblocksseries.com 
Join the conversation online with #NaturesBuildingBlocks.

Further information: Paul Brennan, Managing Director, Mobile: + 61 427 662 317

About NovoSorb®

NovoSorb® is a novel range of bio-resorbable polymers that can be produced in many formats including, film, fibre, foam, and coatings. NovoSorb® BTM is a dermal scaffold for the regeneration of the dermis when lost through trauma, extensive surgery or burn. PolyNovo's Natures Building Blocks individual film can be found here: www.polynovo.com/naturesbuildingblocks

SOURCE PolyNovo


These press releases may also interest you

at 17:09
Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a meeting of the Psychopharmacologic Drugs Advisory Committee on June 4 to discuss a new drug application for...

at 16:50
More than 12,600 people rallied together this weekend for BMO Walk so Kids Can Talk, in support of Kids Help Phone ? raising $3.7 million and counting for its #FeelOutLoud campaign....

at 16:50
Quest Diagnostics Incorporated , a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends during a fireside...

at 16:45
Danaher Corporation announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Tuesday, May 14, 2024 at 10:40 a.m. PT. The event...

at 16:35
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today...

at 16:30
Bio-Rad Laboratories, Inc. , a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2024. First-quarter 2024 total net sales were $610.8 million, a...



News published on and distributed by: